Verrica Pharmaceuticals Stock Forecast - Period Momentum Indicator
| VRCA Stock | USD 1.28 0.04 3.23% |
Verrica Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Verrica Pharmaceuticals stock prices and determine the direction of Verrica Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Verrica Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Verrica |
| Check Verrica Pharmaceuticals Volatility | Backtest Verrica Pharmaceuticals | Information Ratio |
Verrica Pharmaceuticals Trading Date Momentum
| On November 29 2024 Verrica Pharmaceuticals was traded for 1.28 at the closing time. The top price for the day was 1.30 and the lowest listed price was 1.11 . The trading volume for the day was 636 K. The trading history from November 29, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.78% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Verrica Pharmaceuticals to competition |
Other Forecasting Options for Verrica Pharmaceuticals
For every potential investor in Verrica, whether a beginner or expert, Verrica Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Verrica Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Verrica. Basic forecasting techniques help filter out the noise by identifying Verrica Pharmaceuticals' price trends.Verrica Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Verrica Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Verrica Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Verrica Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Verrica Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Verrica Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Verrica Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Verrica Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Verrica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verrica Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Verrica Pharmaceuticals stock market strength indicators, traders can identify Verrica Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 92961.15 | |||
| Daily Balance Of Power | 0.2105 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 1.21 | |||
| Day Typical Price | 1.23 | |||
| Price Action Indicator | 0.095 | |||
| Period Momentum Indicator | 0.04 |
Verrica Pharmaceuticals Risk Indicators
The analysis of Verrica Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Verrica Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting verrica stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.29 | |||
| Standard Deviation | 9.56 | |||
| Variance | 91.46 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Verrica Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verrica Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verrica Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verrica Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Verrica Pharmaceuticals to cross-verify your projections. For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.84) | Revenue Per Share 0.198 | Quarterly Revenue Growth 27.445 | Return On Assets (0.71) | Return On Equity (20.60) |
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.